Viewing nowCombinationAprovasc Tablet 300/5 mg (Irbesartan, Amlodipine Besylate)
Irbesartan 300mg · Amlodipine Besylate 7mg
Tablet · Prescription medication · Combination
Handok Co., Ltd.

MFDS item code 202303235 · Approved 2023.11.28 · Insurance code 652105930
Treatment of essential hypertension not controlled by irbesartan monotherapy
This medication is used to treat essential hypertension in patients whose blood pressure is not adequately controlled with irbesartan monotherapy.
○ Adults Take 1 tablet once daily with water, with or without food. If possible, it is recommended that you take it at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose of irbesartan be adjusted. However, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. • 150/5 mg: For patients whose blood pressure is not adequately controlled with irbesartan 150 mg monotherapy. • 150/10 mg: For patients whose blood pressure is not adequately controlled with irbesartan 150 mg monotherapy or this medicine at 150/5 mg. • 300/5 mg: For patients whose blood pressure is not adequately controlled with irbesartan 300 mg monotherapy. Patients taking irbesartan and amlodipine as separate medicines may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. In general, blood pressure control over 24 hours is better with irbesartan 150 mg than with irbesartan 75 mg once daily. However, irbesartan 75 mg may be considered in certain cases (such as at the start of treatment, in patients on hemodialysis, or in patients aged 75 years and older). This medicine is not recommended when a reduction in the irbesartan dose (e.g., to 75 mg once daily) is required. ○ Older adults Dose adjustment is generally not necessary. However, in patients aged 75 years and older, irbesartan 75 mg should be considered as the initial dose; therefore, this medicine is not recommended for initial treatment. ○ Patients with renal impairment Dose adjustment is generally not necessary. However, in patients on hemodialysis, irbesartan 75 mg should be considered as the initial dose; therefore, this medicine is not recommended for initial treatment. ○ Patients with hepatic impairment Dose adjustment is generally not necessary in patients with mild to moderate hepatic impairment, but it is recommended that the daily dose of irbesartan not exceed 150 mg. However, there is no clinical experience with irbesartan in patients with severe hepatic impairment.
This medication can cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. Individuals with allergies to this drug or its components, pregnant or breastfeeding women, severe liver dysfunction patients, and those with a history of certain angioedema should not take this medication. Elderly patients, patients with hyperkalemia, liver dysfunction, and heart and kidney disease require special caution while taking this medication, and blood pressure, kidney function, and electrolyte status should be monitored frequently. While taking this medication, side effects such as dizziness, hypotension, hyperkalemia, renal failure, liver dysfunction, and hypoglycemia may occur, so if symptoms appear, consult a healthcare professional immediately. Use caution when taking other antihypertensive medications, diuretics, potassium supplements, lithium, non-steroidal anti-inflammatory drugs, as interactions may occur, and you must inform your healthcare provider about any other medications you are taking. Do not take this medication while pregnant or breastfeeding, and if it is necessary to take it, consult a healthcare professional thoroughly. Safety for children has not been established; elderly patients over 75 years should start with a low dose and be administered cautiously. In case of overdose, hypotension, tachycardia, and in severe instances shock can occur, so seek appropriate treatment immediately at a medical facility. This medication should be stored out of reach of children and should not be transferred to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it must be stored in a tightly closed container. Additionally, it is recommended to store it at room temperature between 1 to 30 degrees Celsius, avoiding direct sunlight.
Yellow oval film-coated tablets
Bottle - 100 tablets/bottle, Bottle - 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationIrbesartan 300mg · Amlodipine Besylate 7mg
Tablet · Prescription medication · Combination
Handok Co., Ltd.
CombinationIrbesartan 150mg · Amlodipine Besylate 7mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationIrbesartan 150mg · Amlodipine Besylate 14mg
Tablet · Prescription medication · Combination
Handok Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.